Pfizer Sues Alembic Over Lyrica ANDA

Law360, New York (December 8, 2011, 6:30 PM EST) -- Pfizer Inc. and Northwestern University launched a suit in Delaware federal court Thursday accusing Alembic Ltd. of infringing a patent for nerve pain drug Lyrica by seeking approval to sell a generic version of the drug.

Gujarat, India-based Alembic submitted an abbreviated new drug application to the U.S. Food and Drug Administration that allegedly infringes the claims of U.S. Patent Number 6,197,819, titled “Gamma amino butyric acid analogs and optical isomers,” according to the complaint.

The patent covers pregabalin, sold by Pfizer under the name Lyrica,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.